Form 4: RxSight Executive Ilya Goldshleger Executes Stock Option and Sells Shares

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock on October 4 and October 8, 2024, according to a Form 4 filing with the SEC.

Summary

• Ilya Goldshleger, Co-President and COO of RxSight, Inc., filed a Form 4 with the SEC detailing changes in beneficial ownership.
• On October 4, 2024, Goldshleger exercised options to acquire 3,100 shares of common stock at a price of $15.08 per share and sold 2,866 shares at a weighted average price of $47.9572, 28 shares at $48.47, and 206 shares at $48.65.
• On October 8, 2024, Goldshleger exercised options to acquire 3,100 shares of common stock at a price of $15.08 per share and sold 3,100 shares at a weighted average price of $48.262.
• Following these transactions, Goldshleger directly owns 42,246 shares of common stock and indirectly owns 1,372 shares through a spouse.
• Goldshleger also directly owns 93,502 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard disclosure of insider trading activity. The transactions themselves don't necessarily indicate a positive or negative outlook.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be used by investors to gauge management's sentiment about the company's prospects.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies.
• Monitoring these transactions is a standard practice for investors to understand the sentiment of company insiders.
• The filing is consistent with standard SEC reporting requirements for insider transactions.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.
• The sales could potentially exert downward pressure on the stock price, although the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates